Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November 2013 Volume 30 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November 2013 Volume 30 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells

  • Authors:
    • Kriengsak Lirdprapamongkol
    • Hiroaki Sakurai
    • Sherif Abdelhamed
    • Satoru Yokoyama
    • Takeyuki Maruyama
    • Sirivan Athikomkulchai
    • Amornrat Viriyaroj
    • Suresh Awale
    • Hideo Yagita
    • Somsak Ruchirawat
    • Jisnuson Svasti
    • Ikuo Saiki
  • View Affiliations / Copyright

    Affiliations: Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok 10210, Thailand, Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan, Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok 26120, Thailand, Frontier Research Core for Life Sciences, University of Toyama, Toyama 930-0194, Japan, Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan, Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Bangkok 10210, Thailand
  • Pages: 2357-2364
    |
    Published online on: August 20, 2013
       https://doi.org/10.3892/or.2013.2667
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tumor hypoxia commonly occurs in solid tumors, and correlates with metastasis. Current cancer therapies are inefficient in curing metastatic disease. Herein, we examined effect of Thai propolis extract and its major constituent, chrysin, on hypoxic survival of 4T1 mouse breast cancer cells in vitro, and investigated its underlying mechanism. In vivo effect of chrysin on metastatic progression of cancer cells was studied, both as a single agent and in combination with another antimetastatic agent, agonistic monoclonal antibody targeting the DR5 TRAIL receptor (DR5 mAb). Thai propolis extract and chrysin decreased survival of 4T1 cells after exposure to hypoxia (1% O2), for 2 days. Immunoblot analysis revealed that chrysin inhibited hypoxia-induced STAT3 phosphorylation without affecting HIF-1α protein level. Chrysin also abrogated hypoxia-induced VEGF gene expression as determined by qRT-PCR. The in vivo effect of chrysin was determined in a spontaneous metastasis mouse model of breast cancer, either alone or in combination with DR5 mAb. Daily oral administration of chrysin in Balb/c mice implanted with 4T1 cells significantly suppressed growth of lung metastatic colonies. Moreover, antimetastatic activity of DR5 mAb was enhanced when given in combination with chrysin. We demonstrate that chrysin has potential in controlling metastatic progression.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Takeda K, Yamaguchi N, Akiba H, et al: Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy. J Exp Med. 199:437–448. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Hattori H, Okuda K, Murase T, et al: Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis. Bioorg Med Chem. 19:5392–5401. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Brizel DM, Scully SP, Harrelson JM, et al: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:941–943. 1996.PubMed/NCBI

5 

Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:4509–4515. 1996.PubMed/NCBI

6 

Li XF, Carlin S, Urano M, Russell J, Ling CC and O’Donoghue JA: Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res. 67:7646–7653. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Li XF and O’Donoghue JA: Hypoxia in microscopic tumors. Cancer Lett. 264:172–180. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Iglesias P, Fraga M and Costoya JA: Defining hypoxic microenvironments by non-invasive functional optical imaging. Eur J Cancer. 49:264–271. 2013. View Article : Google Scholar : PubMed/NCBI

9 

McDonnell CO, Hill AD, McNamara DA, Walsh TN and Bouchier-Hayes DJ: Tumour micrometastases: the influence of angiogenesis. Eur J Surg Oncol. 26:105–115. 2000. View Article : Google Scholar : PubMed/NCBI

10 

Minet E, Michel G, Mottet D, Raes M and Michiels C: Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic Biol Med. 31:847–855. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Jung JE, Lee HG, Cho IH, et al: STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19:1296–1298. 2005.PubMed/NCBI

12 

Barr MP, Bouchier-Hayes DJ and Harmey JJ: Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. Int J Oncol. 32:41–48. 2008.PubMed/NCBI

13 

Zhang J, Lu A, Beech D, Jiang B and Lu Y: Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis. Cancer Ther. 5:273–286. 2007.PubMed/NCBI

14 

Sun LP, Chen AL, Hung HC, et al: Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem. 60:11748–11758. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Zhao X, Shu G, Chen L, Mi X, Mei Z and Deng X: A flavonoid component from Docynia delavayi (Franch.) Schneid represses transplanted H22 hepatoma growth and exhibits low toxic effect on tumor-bearing mice. Food Chem Toxicol. 50:3166–3173. 2012.PubMed/NCBI

16 

Fu B, Xue J, Li Z, Shi X, Jiang BH and Fang J: Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol Cancer Ther. 6:220–226. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Wagner H, Chari VM and Sonnenbichler J: 13C-NMR-spektren natürlich vorkommender flavonoide. Tetrahedron Lett. 17:1799–1802. 1976.(In German).

18 

Gaydou E and Bianchini J: Etudes de composés flavoniques. I. Syntheses et propriétés (UV, RMN du 13C) de quelques flavones. Bull Soc Chim Fr II. 43–47. 1978.(In French).

19 

Lirdprapamongkol K, Mahidol C, Thongnest S, et al: Anti-metastatic effects of aqueous extract of Helixanthera parasitica. J Ethnopharmacol. 86:253–256. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A and Svasti J: Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 422:429–435. 2012. View Article : Google Scholar

21 

Mitra SK, Mikolon D, Molina JE, et al: Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene. 25:5969–5984. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Yang H, Xu Z, Iuvone PM and Grossniklaus HE: Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. Mol Vis. 12:511–517. 2006.

23 

Lin CM, Shyu KG, Wang BW, Chang H, Chen YH and Chiu JH: Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach. J Agric Food Chem. 58:7082–7087. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Walle T, Otake Y, Brubaker JA, Walle UK and Halushka PV: Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol. 51:143–146. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB and Chambers AF: Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res. 65:3396–3403. 2005.PubMed/NCBI

26 

Huang J, Frischer JS, Serur A, et al: Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci USA. 100:7785–7790. 2003. View Article : Google Scholar : PubMed/NCBI

27 

Guba M, von Breitenbuch P, Steinbauer M, et al: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 8:128–135. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Lunt SJ, Cawthorne C, Ali M, et al: The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy. Br J Cancer. 103:201–208. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Maruyama T, Athikomkulchai S, Viriyaroj A, Awale S, Yagita H, Ruchirawat S, Ruchirawat S, et al: A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncol Rep 30: 2357-2364, 2013.
APA
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S. ... Saiki, I. (2013). A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncology Reports, 30, 2357-2364. https://doi.org/10.3892/or.2013.2667
MLA
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S., Viriyaroj, A., Awale, S., Yagita, H., Ruchirawat, S., Svasti, J., Saiki, I."A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells". Oncology Reports 30.5 (2013): 2357-2364.
Chicago
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S., Viriyaroj, A., Awale, S., Yagita, H., Ruchirawat, S., Svasti, J., Saiki, I."A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells". Oncology Reports 30, no. 5 (2013): 2357-2364. https://doi.org/10.3892/or.2013.2667
Copy and paste a formatted citation
x
Spandidos Publications style
Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Maruyama T, Athikomkulchai S, Viriyaroj A, Awale S, Yagita H, Ruchirawat S, Ruchirawat S, et al: A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncol Rep 30: 2357-2364, 2013.
APA
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S. ... Saiki, I. (2013). A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncology Reports, 30, 2357-2364. https://doi.org/10.3892/or.2013.2667
MLA
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S., Viriyaroj, A., Awale, S., Yagita, H., Ruchirawat, S., Svasti, J., Saiki, I."A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells". Oncology Reports 30.5 (2013): 2357-2364.
Chicago
Lirdprapamongkol, K., Sakurai, H., Abdelhamed, S., Yokoyama, S., Maruyama, T., Athikomkulchai, S., Viriyaroj, A., Awale, S., Yagita, H., Ruchirawat, S., Svasti, J., Saiki, I."A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells". Oncology Reports 30, no. 5 (2013): 2357-2364. https://doi.org/10.3892/or.2013.2667
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team